Glucagon-like peptide-1 receptor agonists, also known as GLP-1 analogs, GLP-1RAs, or incretin mimetics, are a class of anorectic drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor. From Wikipedia
New findings show surgery delivers more durable weight loss with lower psychiatric risks compared to weekly semaglutide or tirzepatide injections.
